TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Boston Scientific Nordic AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
120,929
|
107,424
|
106,509 |
| Financial expenses |
74
|
41
|
10 |
| Earnings before taxes |
3,868
|
2,867
|
3,592 |
| EBITDA |
4,445
|
3,511
|
4,163 |
| Total assets |
39,978
|
37,823
|
36,045 |
| Current assets |
38,070
|
36,136
|
34,373 |
| Current liabilities |
20,575
|
21,019
|
19,891 |
| Equity capital |
19,402
|
16,804
|
16,154 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
126
|
120
|
113 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
48.5%
|
44.4%
|
44.8% |
| Turnover per employee |
960
|
895
|
943 |
| Profit as a percentage of turnover |
3.2%
|
2.7%
|
3.4% |
| Return on assets (ROA) |
9.9%
|
7.7%
|
10.0% |
| Current ratio |
185.0%
|
171.9%
|
172.8% |
| Return on equity (ROE) |
19.9%
|
17.1%
|
22.2% |
| Change turnover |
13,192
|
9,543
|
6,852 |
| Change turnover % |
12%
|
10%
|
7% |
| Chg. No. of employees |
6
|
7
|
2 |
| Chg. No. of employees % |
5%
|
6%
|
2% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.